Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III

APMIS

Volumn 106, Issue 3, 1998, Pages 417-424

  Olsen, Anne O ^a   Ørstavik, Ivar ^a   Dillner, Joakim ^b   Vestergaard, Bent Faber ^c   Magnus, Per ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

CIN; ELISA; HPV; HSV; PCR

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX VIRUS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; SEROCONVERSION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CAPSID; WART VIRUS;

EID: 0031972354     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb01366.x     Document Type: Article

References (39)

1. Andersson Ellstrøm, A., Dillner, J., Hagmar, B., Schiller, J., Sapp, M., Forssman, L. & Milsom, I.: Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex. Transm. Dis. 23: 234-238, 1996.
2. Becker, T. M., Wheeler, C. M., McGough, N. S., Parmenter, C. A., Jordan, S. W., Stidley, C. A., McPherson, R. S. & Dorin, M. H.: Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 271: 1181-1188, 1994.
3. Christie, S. N., McCaughey, C., McBride, M. & Coyle, P. V.: Herpes simplex type 1 and genital herpes in Northern Ireland. Int. J. STD AIDS 8: 68-69, 1997.
4. Daling, J. R., Madeleine, M. M., McKnight, B., Carter, J. J., Wipf, G. C., Ashley, R., Schwartz, S. M., Beckmann, A. M., Hagensee, M. E., Mandelson, M. T. & Galloway, D. A.: The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol. Biomarkers Prev. 5: 541-548, 1996.
5. Das, C. M., Zhang, S., & Shillitoe, E. J.: Expression of the mutagenic peptide of herpes simplex virus type 1 in virus-infected cells. Virus Res. 34: 97-114, 1994.
6. de Sanjose, S., Munoz, N., Bosch, F. X., Reimann, K., Pedersen, N. S., Orfila, J., Ascunce, N., Gonzalez, L. C., Tafur, L., Gili, M. et al.: Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int. J. Cancer 56: 358-363, 1994.
7. Dean, A. G., Dean, J. A., Burton, A. H. & Dicker, R. C.: Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta, Georgia, USA: Centers for Disease Control and Prevention 1994.
8. Dhanwada, K. R., Garrett, L., Smith, P., Thompson, K. D., Doster, A. & Jones, C.: Characterization of human keratinocytes transformed by high risk human papillomavirus types 16 or 18 and herpes simplex virus type. J. Gen. Virol. 74: 955-963, 1993.
9. Dillner, J., Kallings, I., Brihmer, C., Sikstrom, B., Koskela, P., Lehtinen, M., Schiller, J. T., Sapp, M. & Mårdh, P. A.: Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamvdia trachomatis are markers of sexual behavior. J. Infect. Dis. 173: 1394-1398, 1996.
10. Dillner, J., Lenner, P., Lehtinen, M., Eklund, C., Heino, P., Wiklund, F., Hallmans, G. & Stendahl, U.: A population-based seroepidemiological study of cervical cancer. Cancer Res. 54: 134-141, 1994.
11. DiPaolo, J. A., Woodworth, C. D., Popescu, N. C., Koval, D. L., Lopez, J. V. & Doniger, J.: HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes. Virology 177: 777-779, 1990.
12. Galloway, D. A. & McDougall, J. K.: The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 302: 21-24, 1983.
13. Gjøen, K., Siebke, J. C, Flikke, M., Häger, R., Ertzeid, G., Halsos, A., Ekgren, J., Norling, B., Grinde, B. & Ørstavik, I.: Genital human papilloma virus infection in Oslo studied by dot blot DNA hybridization and the polymerase chain reaction. J. Med. Virol. 34: 159-164, 1991.
14. Greenland, S. & Thomas, D. C.: On the need for the rare disease assumption in case-control studies. Am. J. Epidemiol. 116: 547-553, 1982.
15. Hakama, M., Lehtinen, M., Knekt, P., Aromaa, A., Leinikki, P., Miettinen, A., Paavonen, J., Peto, R. & Teppo, L.: Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am. J. Epidemiol. 137: 166-170, 1993.
16. Hildesheim, A., Mann, V., Brinton, L. A., Szklo, M., Reeves, W. C. & Rawls, W. E.: Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int. J. Cancer 49: 335-340, 1991.
17. Hosmer, D. W. & Lemeshow, S.: Confidence interval estimation of interaction. Epidemiology 3: 452-456, 1992.
18. Jha, P. K., Beral, V., Peto, J., Hack, S., Hermon, C., Deacon, J., Mant, D., Chilvers, C., Vessey, M. P., Pike, M. C. et al.: Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet 341: 1116-1118, 1993.
19. Jones, C.: Cervical cancer: is herpes simplex virus type II a cofactor? Clin. Microbiol. Rev. 8: 549-556, 1995.
20. Kirnbauer, R., Hubbert, N. L. Wheeler, C. M., Becker, T. M., Lowy, D. R. & Schiller, J. T.: A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. Natl. Cancer Inst. 86: 494-499, 1994.
21. Kjœr, S. K., de Villiers, E. M., Caglayan, H., Svare, E., Haugaard, B. J., Engholm, G., Christensen, R. B., Moller, K. A., Poll, P., Jensen, H. et al.: Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark) - a second look. Br. J. Cancer 67: 830-837, 1993.
22. Lavery, H. A., Connolly, J. H. & Russell, J. D.: Incidence of herpes genitalis in Northern Ireland in 1973-83 and herpes simplex types 1 and 2 isolated in 1982-4. Genitourin. Med. 62: 24-27, 1986.
23. Miettinen, O.: Estimability and estimation in case-referent studies. Am. J. Epidemiol. 103: 226-235, 1976.
24. Munoz, N., Bosch, F. X., de Sanjose, S., Vergara, A., del Moral, A., Munoz, M. T., Tafur, L., Gili, M., Izarzagaza, I., Viladiu, P. et al.: Risk factors for cervical intraepithelial neoplasia grade III/ carcinoma in situ in Spain and Colombia. Cancer Epidemiol. Biomarkers Prev. 2: 423-431, 1993.
25. Norusis, M. J.: SPSS for windows: Advanced statistics. 6.0. Chicago, USA: SPSS INC. 1993.
26. Olsen, A. O., Dillner, J., Gjøen, K., Sauer, T., Ørstavik, I. & Magnus, P.: A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix. Int. J. Cancer 68: 415-419, 1996.
27. Olsen, A. O., Dillner, J., Gjøen, K. & Magnus, P.: Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA. Genitourin. Med. 73: 131-135, 1997.
28. Olsen, A. O., Gjøen, K., Sauer, T., Ørstavik, I., Nœss, O., Kierulf, K., Sponland, G., & Magnus, P.: Human papillomavirus and cervical intra-epithelial neoplasia grade II-III: a population-based case-control study. Int. J. Cancer 61: 312-315, 1995.
29. Rodgers, C. A. & O'Mahony, C.: High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex. Int. J. STD AIDS 6: 144, 1995.
30. Rothman, K. J.: Modern Epidemiology. Little, Brown and Company, Boston/Toronto 1986, pp. 311-326.
31. Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S. et al.: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85: 958-964, 1993.
32. Scoular, A., Leask, B. G. & Carrington, D.: Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88. Genitourin. Med. 66: 226, 1990.
33. Steele, C. & Shillitoe, E. J.: Viruses and oral cancer. Crit. Rev. Oral Biol. Med. 2: 153-175, 1991.
34. Stone, K. M., Zaidi, A., Rosero Bixby, L., Oberle, M. W., Reynolds, G., Larsen, S., Nahmias, A. J., Lee, F. K., Schachter, J. & Guinan, M. E.: Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology 6: 409-414, 1995.
35. Tayal, S. C. & Pattman, R. S.: High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex in Newcastle upon Tyne 1983-92. Int. J. STD AIDS 5: 359-361, 1994.
36. Vestergaard, B. F. & Grauballe, P. C: ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using type-heterologous rabbit antibodies. Acta path. microbiol. immunol. scand. B 87: 261-263, 1979.
37. Vestergaard, B. F., Grauballe, P. C. & Spanggaard, H.: Titration of herpes simplex virus antibodies in human sera by the enzyme-linked immunosorbent assay (ELISA). Acta path. microbiol. immunol. scand. B 85: 466-468, 1977.
38. Williamson, A. L. & Rybicki, E. P.: Detection of genital human papillomaviruses by polymerase chain reaction amplification with degenerate nested primers. J. Med. Virol. 33: 165-171, 1991.
39. zur Hausen, H.: Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet 2: 1370-1372, 1982.